← Browse by Condition
Medical Condition
chemotherapy induced peripheral neuropathy
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for chemotherapy induced peripheral neuropathy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — chemotherapy induced peripheral neuropathy Clinical Trials
How many clinical trials are currently recruiting for chemotherapy induced peripheral neuropathy?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for chemotherapy induced peripheral neuropathy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chemotherapy induced peripheral neuropathy?
chemotherapy induced peripheral neuropathy research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chemotherapy induced peripheral neuropathy clinical trial?
Eligibility criteria for chemotherapy induced peripheral neuropathy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04763356
Recruiting
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
Enrollment
422 pts
Location
United States
Sponsor
University of Vermont
NCT07016971 Phase 1
Recruiting
CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy
Enrollment
12 pts
Location
United States
Sponsor
Milton S. Hershey Medical Cent...
NCT05411523
Recruiting
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Enrollment
20 pts
Location
United States
Sponsor
Mayo Clinic
NCT06737926
Recruiting
Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients
Enrollment
24 pts
Location
Pakistan
Sponsor
Riphah International Universit...
NCT05904340
Recruiting
Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy
Enrollment
86 pts
Location
Taiwan
Sponsor
National Taipei University of ...
NCT06052345
Recruiting
Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes
Enrollment
100 pts
Location
Sweden
Sponsor
Theodoros Foukakis
NCT04786977
Recruiting
Physiologic Measure of VIPN
Enrollment
40 pts
Location
United States
Sponsor
Children's National Research I...
NCT04970121 Phase 2
Recruiting
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
Enrollment
100 pts
Location
China
Sponsor
Yan Yang, MD, Ph.D
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology